Chlamydia



Phase 2B Double-blinded Placebo-controlled Efficacy Trial of Amphora® Gel


Condition:   Chlamydia Trachomatis Infection
Interventions:   Drug: Amphora gel;   Drug: Placebo
Sponsors:   Evofem Inc.;   Clinical Research Management, Inc.
Not yet recruiting - verified April 2017


Use of a Rapid Turnaround Test for NG/CT to Improve Treatment of Women Presenting With Possible STIs


Conditions:   Sexually Transmitted Infection;   Gonorrhea Female;   Chlamydia Females
Interventions:   Device: Cepheid Xpert CT/NG Rapid Turnaround Test;   Device: Polymerase chain reaction (PCR)
Sponsor:   University of Maryland
Not yet recruiting - verified March 2017


Check it: A New Approach to Controlling Chlamydia Transmission in Young People


Conditions:   Chlamydia Trachomatis Infection;   Gonorrhea
Intervention:   Other: Ct/GC screening
Sponsors:   Tulane University;   National Institutes of Health (NIH);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not yet recruiting - verified April 2017


MAMAS: Mentoring Adolescent Mothers at School


Conditions:   Human Immunodeficiency Virus;   Herpes Simplex Type II;   Chlamydia;   Gonorrhea;   Trichomonas Vaginitis
Intervention:   Behavioral: Mentoring Adolescent Mothers at School (MAMAS)
Sponsors:   Drexel University;   University of KwaZulu;   University of North Carolina, Chapel Hill
Not yet recruiting - verified May 2017


Evaluation of the Atlas Genetics io® CTNG System


Conditions:   Chlamydia Trachomatis;   Gonorrhea
Intervention:   Device: Atlas Genetics io® system
Sponsor:   Atlas Genetics Limited
Recruiting - verified May 2017


Screening of Gonococcal and Chlamydial Infections in the Third Trimester


Conditions:   Gonococcal Infection;   Chlamydia Infections
Intervention:  
Sponsor:   St. Michael's Hospital, Toronto
Enrolling by invitation - verified March 2017


STI Screening as a Combined HIV Prevention Platform for MSM in Peru


Conditions:   Gonorrhoea of Rectum;   Chlamydia of Rectum;   HIV Infections
Interventions:   Behavioral: PCC;   Behavioral: Traditional Counseling
Sponsors:   University of California, Los Angeles;   NGO Via Libre;   University of California, San Francisco
Not yet recruiting - verified May 2017


Prevention of Diseases Induced by Chlamydia Trachomatis


Condition:   Genital Chlamydia Trachomatis Infection
Interventions:   Other: Testing for Ct infection immediately;   Other: Testing for Ct infection at the end of the study
Sponsors:   Assistance Publique - Hôpitaux de Paris;   National Reference Center (NRC) for Chlamydia infections, UMR1181
Recruiting - verified January 2017


Kinetics and Ecology of Human Papillomavirus Genital Infections in Young Women


Conditions:   HPV Genital Infection (Primary Condition Studied);   Bacterial Vaginosis;   Chlamydiae Infection
Intervention:   Other: vaginal sampling
Sponsors:   University Hospital, Montpellier;   Université Montpellier
Recruiting - verified November 2016


Performance of Nucleic Acid Amplification Tests for the Detection of NG and CT


Conditions:   Neisseria Gonorrhoeae Infection;   Chlamydia Trachomatis Infection;   Sexually Transmitted Diseases
Interventions:   Device: NAAT 1 to Detect Rectal and Pharyngeal NG and CT;   Device: NAAT 2 to Detect Rectal and Pharyngeal NG and CT;   Device: NAAT 3 to Detect Rectal and Pharyngeal NG and CT;   Device: NAAT 4 to Detect Rectal and Pharyngeal NG;   Device: NAAT 4 to Detect Rectal and Pharyngeal CT
Sponsors:   Duke University;   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2017


Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples


Conditions:   Chlamydia Trachomatis;   Gonorrhea
Intervention:  
Sponsor:   Hologic, Inc.
Terminated - verified March 2017


Safety of Chlamydia Vaccine CTH522 in Healthy Women Aged 18 to 45 Years


Condition:   Chlamydia Trachomatis
Interventions:   Biological: CTH522-CAF01;   Biological: CTH522-Al(OH)3;   Biological: Placebo
Sponsors:   Statens Serum Institut;   Imperial College London
Recruiting - verified October 2016


Love, Sex & Choices: A Web Series on Mobile Devices to Reduce Black Women's HIV Risk


Conditions:   HIV;   Sexual Behavior;   Women's Role;   Risk Behavior;   Chlamydia
Intervention:   Behavioral: Love, Sex, & Choices
Sponsors:   Northeastern University;   National Institute of Nursing Research (NINR)
Recruiting - verified September 2016


Texting Intervention to Sustain HIV Prevention in Women in High-drug-use Contexts


Conditions:   HIV;   Syphilis;   Gonorrhea;   Chlamydia
Interventions:   Behavioral: Mujer Segura Siempre;   Behavioral: General Health Message Texts
Sponsors:   University of California, San Diego;   Comisión de Salud Fronteriza México-Estados Unidos (CSFMEU)
Active, not recruiting - verified May 2017


Multimedia WORTH With Black Drug-Involved Women on Probation


Conditions:   Sexually Transmitted Infections;   HIV;   Gonorrhea;   Trichomonas;   Chlamydia Trachomatis;   Drug Use
Interventions:   Behavioral: E-WORTH;   Behavioral: Streamlined HIV Testing
Sponsors:   Columbia University;   Fortune Society;   University of Pennsylvania;   State University of New York - Downstate Medical Center;   RTI International;   Duke University;   National Institute on Drug Abuse (NIDA)
Recruiting - verified August 2016


Emergency Department, Rapid Assessment for Sexually Transmitted Infection


Condition:   Infection
Intervention:  
Sponsors:   Henry Ford Health System;   Cepheid
Completed - verified January 2017


Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea


Condition:   Uncomplicated Urogenital Gonorrhea
Interventions:   Drug: solithromycin;   Drug: ceftriaxone;   Drug: azithromycin
Sponsors:   Cempra Inc;   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified September 2016


Implementation of a Sexual Health Intervention for Young Men Who Have Sex With Men (MSM) in Two Vietnamese Cities


Conditions:   HIV;   Chlamydia;   Gonorrhea;   Syphilis;   Hepatitis C
Intervention:   Behavioral: Sexual Health Promotion Intervention
Sponsors:   National Development and Research Institutes, Inc.;   National Institute on Drug Abuse (NIDA);   Hanoi Medical University;   University of Puerto Rico
Completed - verified October 2015


Detection of Chlamydia (CT) and Gonorrhea (NG)


Conditions:   Chlamydia;   Gonorrhea
Intervention:   Device: illumigene CT and NG assays, illumipro-10
Sponsor:   Meridian Bioscience, Inc.
Unknown status - verified September 2014


Self-Obtained Vaginal Swabs for Chlamydia and Gonorrhea Testing


Conditions:   Chlamydial Infection;   Gonococcal Infection
Intervention:  
Sponsors:   University of California, San Francisco;   University of Alabama at Birmingham
Completed - verified June 2016


Keep It Up! 2.0: A Comparison of Two Online HIV Intervention Programs for Young Men Who Have Sex With Men


Conditions:   HIV;   Gonorrhea;   Chlamydia
Interventions:   Behavioral: Keep It Up!;   Behavioral: HIV Knowledge Control
Sponsors:   Northwestern University;   National Institute on Drug Abuse (NIDA);   Emory University;   Hunter College of City University of New York
Active, not recruiting - verified January 2017


Antigen-Specific Cell Mediated Immune Response to Chlamydia Trachomatis


Condition:   Chlamydia
Intervention:  
Sponsors:   University of Pittsburgh;   National Institutes of Health (NIH);   National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified April 2017


A Validation Study for Detecting Chlamydia and Gonorrhea in Rectal Samples


Conditions:   Gonorrhea;   Chlamydia
Intervention:   Other: Gen-Probe APTIMA Combo2 (AC2)
Sponsors:   University of Pittsburgh;   National Institutes of Health (NIH);   National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified August 2016


Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria


Conditions:   Arthritis, Reactive;   Reiter Disease
Interventions:   Drug: Doxycycline and Rifampin;   Drug: Azithromycin and Rifampin;   Drug: Placebo
Sponsors:   University of South Florida;   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Completed - verified June 2016


Pediatrics:Chlamydia, Sickle Cell Anemia and Stroke Risk - Ancillary to STOP II


Conditions:   Blood Disease;   Anemia, Sickle Cell;   Chlamydia Infections;   Cerebrovascular Accident
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified January 2008

Refine Your Search Advanced Search